Cardiokine cardiokine.com


Public lists: Pharma Startups (4732)

CardioKine develops pharmaceuticals for cardio-renal diseases. Their lead product lixivaptan is a sodium-sparing diuretic for the treatment of heart failure and electrolyte imbalances. In December 2011, CardioKine was acquired by Cornerstone Therapeutics through a merger. The valuation of CardioKine was undisclosed. Other terms of the deal were not released.

CardioKine develops pharmaceuticals for cardio-renal diseases. Their lead product lixivaptan is a sodium-sparing diuretic for the treatment of heart failure and electrolyte imbalances. In December 2011, CardioKine was acquired by Cornerstone The...Show all

Company (Acquired)

Phone:

Fax:

30 South 15th Street
15th Floor
Philadelphia, 19102
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cardiokine $87M Dec 22, 2011
ARCA Biopharma $75M Jun 8, 2007
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cardiokine Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors

Competitors

Company Status Description Investors
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)